Venus Remedies Declares Unaudited Financial Results for Q1 FY27

Venus Remedies Limited announced that its Board of Directors, in a meeting held on July 20, 2026, approved the unaudited financial results (Consolidated and Standalone) for the quarter ended June 30, 2026. The company also approved revisions to the proposed alteration of its Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act, 2013, and current business practices. The revised MOA will be presented to shareholders for approval via a special resolution at the upcoming 37th Annual General Meeting. The trading window for designated persons remains closed until 48 hours after the declaration of financial results.